A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [72]
In the citing paper
“This association has been replicated either directly or using highly correlated SNPs by several groups (92–97).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“The replicated nicotine dependence loci tagged by rs16969968 (96,100–102) and rs578776 (101,103) have also been reported to influence lung cancer risk in several genome-wide association studies.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“This second association with nicotine dependence has been replicated in additional studies using the same SNP or a highly correlated SNP (92,95,96,98).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationGenotype-environment interaction and correlation in the analysis of human behavior.
Plomin, R., DeFries, J. C., & Loehlin, J. C. (1977) · Psychological Bulletin · doi:10.1037/0033-2909.84.2.309 · Cited by 1,685
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Cited by
Items 701–800 of 1,002
Okazaki, I., Ishikawa, S., & Sohara, Y. (2014) · PubMed · Cited by 31
Genome-wide association studies for detecting cancer susceptibility
Hosking, F. J., Dobbins, S. E., & Houlston, R. S. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldq038 · Cited by 30
Bandiera, F. C., Ross, K. C., Taghavi, S., Delucchi, K., Tyndale, R. F., & Benowitz, N. L. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu337 · Cited by 26
Hällfors, J., Palviainen, T., Surakka, I. L., Gupta, R., Buchwald, J., Raevuori, A., Ripatti, S., Korhonen, T., Jousilahti, P., Madden, P. A. F., et al. (2018) · Addiction Biology · doi:10.1111/adb.12618 · Cited by 28
“A functional variant D398N has been identified in CHRNA5 (Bierut et al. 2008); however, alleles at this locus explain less than 1 percent of the variance in amount smoked (Thorgeirsson et al. 2008), and about 4–5 percent of the variance in cotinine levels (Keskitalo et al. 2009; Munafo et al. 2012).”
BackgroundFrom Genes to Treatments: A Systematic Review of the Pharmacogenetics in Smoking Cessation
Salloum, N. C., Buchalter, E. L. F., Chanani, S., Espejo, G. D., Ismail, M. S., Laine, R. O., Nageeb, M., Srivastava, A. B., Trapp, N. T., Trillo, L., et al. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0023 · Cited by 26
“One of the most studied gene clusters is CHRNA5-A3-B4, which has been heavily linked to smoking characteristics including nicotine dependence [29], smoking quantity [90] and biomarkers of smoking [91,92].”
BackgroundBen, J., Jin, G., Zhang, Y., Ma, B., Bai, H., Chen, J., Zhang, H., Gong, Q., Zhou, X., Zhang, H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0592oc · Cited by 27
Ravenel, J. G., Costello, P., & Silvestri, G. A. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2899 · Cited by 26
Li, Z., Yang, D., Wei, Z., Huang, J., Chi, Y.-Q., Lu, Y., & Yin, F. (2024) · Biotechnology for Biofuels and Bioproducts · doi:10.1186/s13068-024-02593-3 · Cited by 27
“A large amount of high nicotine tobacco is produced every year, which not only seriously affects the flavor of tobacco products, but also increases their harmfulness [5–12].”
CHRNA5 polymorphisms and risk of lung cancer in Chinese Han smokers.
Huang, C., Xun, X., A-jing, W., Gao, Y., Ma, J., Chen, Y.-T., Jin, T., Hou, P., & Gu, S. (2015) · Europe PMC (PubMed Central) · Cited by 25
Qian, J., Liu, Y., Sun, Z., Zhangsun, D., & Luo, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172674 · Cited by 29
Pérez-Páramo, Y. X., & Lazarus, P. J. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1863948 · Cited by 26
“For example, the genetic variant rs1051730 located in the CHRNA3 gene is highly linked to rs16969968 [linkage disequilibrium (LD) r2 = 0.987] and is associated with smoking quantity and short-term smoking cessation among Europeans [24,26,37].”
BackgroundInfluentialCippitelli, A., Brunori, G., Gaiolini, K. A., Zaveri, N. T., & Toll, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.005 · Cited by 26
Khroyan, T. V., Yasuda, D. M., Toll, L., Polgar, W. E., & Zaveri, N. T. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.083 · Cited by 25
Johnsen, M. B., Vie, G. Å., Winsvold, B. S., Bjørngaard, J. H., Åsvold, B. O., Gabrielsen, M. E., Pedersen, L. M., Hellevik, A. I., Langhammer, A., Furnes, O. N., et al. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.12.021 · Cited by 26
Liu, Q., Han, H., Wang, M., Yao, Y., Li, W., Jiang, K., Ma, Y., Fan, R., Chen, J., Su, K., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0130-x · Cited by 26
“In addition, a significant association has been reported of variants in the CHRNA5/A3/B4 cluster with ND and lung cancer.(18)”
BackgroundGenetics of addictive behavior: the example of nicotine dependence
Gorwood, P. A. P. M., Strat, Y. L., & Ramoz, N. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/pgorwood · Cited by 28
Chen, J., Lee, G., Fanous, A. H., Zhao, Z., Jia, P., O’Neill, F. A., Walsh, D., Kendler, K. S., & Chen, X. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.023 · Cited by 37
“…including type 2 diabetes (Scott et al., 2007; Sladek et al., 2007; Zeggini et al., 2007), lung cancer (Amos et al., 2008; Spitz et al., 2008; Thorgeirsson et al., 2008), Parkinson's disease (Satake et al., 2009; Simon-Sanchez et al., 2009), rheumatoid arthritis (Raychaudhuri et al., 2008),…”
BackgroundTargeting signaling pathways with andrographolide in cancer therapy (Review)
Shaharudin, N. S., Singh, G. K. S., Kek, T., & Sultan, S. (2024) · Molecular and Clinical Oncology · doi:10.3892/mco.2024.2779 · Cited by 28
“According to studies by the Genome‑wide Association, certain variants in several chromosomal regions, such as the 5p15 locus (60), 6p21 locus (61) and 15q25‑26 loci, might increase the prob‑ ability of being diagnosed with lung cancer (55,62).”
BackgroundGenome-wide association study of smoking behaviours among Bangladeshi adults
Argos, M., Lin, T., Pierce, B. L., Rakibuz‐Zaman, M., Ahmed, A., Islam, T., Rahman, M., Paul-Brutus, R., Rahaman, R. O., Roy, S., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102151 · Cited by 25
Xu, H., Wang, F., Kranzler, H. R., Gelernter, J. E., & Zhang, H. (2017) · Scientific Reports · doi:10.1038/srep41816 · Cited by 25
“…29–37 ; three of them reported genome-wide significant results for single nucleotide polymorphisms (SNPs) in exon 5 of CHRNA3 on chromosome 15 32 , the upstream region of IL15 on chromosome 4 33 , the intronic region of DLC1 on chromosome 8 37 , or intergenic regions on chromosomes 7…”
A role for club cells in smoking-associated lung adenocarcinoma
Behrend, S. J., Giotopoulou, G. A., Σπέλλα, Μ., & Stathopoulos, G. T. (2021) · European Respiratory Review · doi:10.1183/16000617.0122-2021 · Cited by 25
Alternative CHRNB4 3′-UTRs Mediate the Allelic Effects of SNP rs1948 on Gene Expression
Gallego, X., Cox, R. J., Laughlin, J. R., Stitzel, J. A., & Ehringer, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063699 · Cited by 25
“The strongest genetic contribution to nicotine dependence comes from variations in the chromosome 15q25 region [17,18,19,20,21,22,23,24,25,26,27,28,29].”
BackgroundPolina, E. R., Rovaris, D. L., de Azeredo, L. A., Mota, N. R., Vitola, E. S., Silva, K. L., Guimarães-da-Silva, P. O., Picon, F. A., Belmonte-de-Abreu, P. S., Rohde, L. A., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8286-2 · Cited by 26
“Several genome-wide association studies (GWAS) have implicated the 15q25 region, especially the CHRNA3 gene, as playing an important role in the susceptibility to smoking behavior (David et al. 2012; Furberg et al. 2010; Liu et al. 2010; Thorgeirsson et al. 2008, 2010).”
BackgroundCassidy, A., Balsan, J., Vesin, A., Wu, X., Liloglou, T., Brambilla, C., Timsit, J., & Field, J. K. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.05.006 · Cited by 24
Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date
Mamoun, M. S., Bergen, A. W., Shieh, J., Wiggins, A., & Brody, A. L. (2015) · CNS Drugs · doi:10.1007/s40263-015-0243-1 · Cited by 28
“Meta-analyses of genome-wide association scans (GWASs) of cigarette smoking behaviors [50–55]”
Genetic imaging consortium for addiction medicine
Mackey, S., Kan, K., Chaarani, B., Alia‐Klein, N., Batalla, A., Brooks, S. J., Cousijn, J., Dagher, A., de Ruiter, M. B., Desrivières, S., et al. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.026 · Cited by 29
Salinas, Y. D., Wang, Z., & DeWan, A. T. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx296 · Cited by 27
Preparing the Way: Exploiting Genomic Medicine to Stop Smoking
Bierut, L. J., & Tyndale, R. F. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.001 · Cited by 24
“High-risk genomic variation in these two regions contributes to disease risk across populations, and multiple phenotypic/genotypic relationships have been established as genetic variation in CHRNA5 and CYP2A6 has been associated with increased risk of heavy smoking, increased intensity of smoking, as well as smoking-r…”
BackgroundGenome-Wide Meta-Analyses of FTND and TTFC Phenotypes
Chen, J., Loukola, A., Gillespie, N. A., Peterson, R. E., Jia, P., Riley, B. P., MAES, H. H. M., Dick, D. M., Kendler, K. S., Damaj, M. I., et al. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz099 · Cited by 25
“We conducted replication study for all loci meeting these four criteria: (1) having five or more SNPs with p-value ≤ 5 × 10−5; (2) at least one SNP with p-value ≤ 5 × 10−5 having a minor allele frequency ≥5%; (3) minor allele frequency variation at the locus > 5% between SNPs with p-value ≤ 5 × 10−5; and (4) at least…”
MethodShurtleff, D., Liu, R., & Sasek, C. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.009 · Cited by 24
Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works
Jett, J. R., & Midthun, D. E. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00367 · Cited by 26
Constrained instruments and their application to Mendelian randomization with pleiotropy
Jiang, L., Oualkacha, K., Didelez, V., Ciampi, A., Rosa‐Neto, P., Benedet, A. L., Mathotaarachchi, S., Richards, J. B., Greenwood, C. M. T., & Initiative, A. F. T. A. D. N. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22184 · Cited by 23
“For example Thorgeirsson et al. (2008) reported a common variant in the nicotinic acetylcholine receptor gene cluster that affects both nicotine dependence (ND) and the smoking quantity (SQ).”
Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans
David, S. P., Wang, A., Kapphahn, K., Hedlin, H., Desai, M., Henderson, M. T., Yang, L., Walsh, K. M., Schwartz, A. G., Wiencke, J. K., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.002 · Cited by 23
“, 2009) — findings similar to a larger study of European-ancestry cases (n = 1024) and controls (n = 32,244) (Thorgeirsson et al., 2008).”
BackgroundResultAssociation between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis
Qu, X. H., Wang, K., Dong, W., Shen, H., Wang, Y., Liu, Q., & Du, J. (2016) · Scientific Reports · doi:10.1038/srep20149 · Cited by 24
Poredoš, P., Šabovič, M., Mijovski, M. B., Starčević, J. N., Antignani, P. L., Paraskevas, K. I., Mikhailidis, D. P., & Blinc, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912054 · Cited by 24
“GWAS investigated PAD-related traits such as smoking [86], coronary artery disease [87], and abdominal aortic aneurysm [88], and demonstrated suggestive PAD associations for the loci 9p21/CDKN2B and CHRNA3.”
BackgroundHällfors, J., Loukola, A., Pitkäniemi, J. M., Broms, U., Männistö, S., Salomaa, V. V., Heliövaara, M., Lehtimäki, T. J., Raitakari, O. T., Madden, P. A. F., et al. (2013) · Europe PMC (PubMed Central) · Cited by 30
A Flexible Bayesian Model for Studying Gene–Environment Interaction
Yu, K. F., Wacholder, S., Wheeler, W., Wang, Z., Caporaso, N. E., Landi, M. T., & Liang, F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002482 · Cited by 25
“1, 5p15, and 6p21) harboring genetic variants underlying a susceptibility for lung cancer [15,16,17].”
BackgroundA systems biology network model for genetic association studies of nicotine addiction and treatment
Thomas, P. D., Mi, H., Swan, G. E., Lerman, C. E., Benowitz, N. L., Tyndale, R. F., Bergen, A. W., & Conti, D. V. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832e2ced · Cited by 24
Autologous bone marrow cell therapy for peripheral arterial disease
Botti, C., Maione, Coppola, Sica, V., & Cobellis, G. (2012) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s28121 · Cited by 23
Zhao, D., Yang, C., Zhou, X. H., Ding, J.-A., & Jiang, G. (2014) · Molecular Genetics and Genomics · doi:10.1007/s00438-014-0868-7 · Cited by 24
“…three genome-wide association studies (GWAS) of lung cancer and subsequent pooled GWAS analyses identified inherited susceptibility variants on chromosome 15q25 (Amos et al. 2008; Hung et al. 2008; Thorgeirsson et al. 2008), 5p15 (McKay et al. 2008; Wang et al. 2008; Rafnar et al. 2009), and 6p21.”
BackgroundSaccone, N. L., Baurley, J. W., Bergen, A. W., David, S. P., Elliott, H. R., Foreman, M. G., Kaprio, J. A., Piasecki, T. M., Relton, C. L., Zawertailo, L. A., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx096 · Cited by 25
“…the 5 cholinergic nicotinic receptor subunit, have come to prominence for their associations with smoking traits including nicotine dependence 38, 56 , smoking quantity and heaviness, e.g. cigarettes per day 16, 40-41, 43 , and biomarkers of smoking Other variants in the surrounding genes…”
BackgroundXu, Y., Zhang, Q., Li, P., Guangfeng, H., Wang, D., Liu, J., Zhou, H., Chai, G., Lu, B., He, S., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05078 · Cited by 25
BDNF Val66Met Variant and Smoking in a Chinese Population
Zhang, X. Y., Chen, D. C., Xiu, M. H., Luο, X., Zuo, L., Haile, C. N., Kosten, T. A., & Kosten, T. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053295 · Cited by 25
In Vitro and Ex Vivo Analysis of CHRNA3 and CHRNA5 Haplotype Expression
Doyle, G. A. R., Wang, M., Chou, A. D., Oleynick, J. U., Arnold, S. E., Buono, R. J., Ferraro, T. N., & Berrettini, W. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023373 · Cited by 24
“Both genome-wide and candidate gene association studies have pointed to the CHRNA5-CHRNA3-CHRNB4 cluster of nAChR subunit genes as being important in the etiology of NA, lung cancer, peripheral artery disease and chronic obstructive pulmonary disease [7–18,29].”
BackgroundAssociation of the CHRNA3 Locus with Lung Cancer Risk and Prognosis in Chinese Han Population
Niu, X., Chen, Z., Shen, S., Liu, Y., Zhou, D., Zhang, J., Li, Z., Yu, Y., Liao, M., Lü, S., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d5e447 · Cited by 23
Xun, W. W., Brennan, P., Tjønneland, A. M., Vogel, U. B., Overvad, K., Kaaks, R., Canzian, F., Boeing, H., Trichopoulou, A. D., Oustoglou, E., et al. (2011) · Mutagenesis · doi:10.1093/mutage/ger030 · Cited by 30
“We have included 31 additional candidate SNPs from the previous GWAS and its replication phase, without a priori underlying biological hypotheses (5,8).”
MethodWacholder, S., Chatterjee, N., & Caporaso, N. E. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn380 · Cited by 23
Tseng, T., Park, J. Y., Zabaleta, J., Moody‐Thomas, S., SOTHERN, M. S., Chen, T., Evans, D. E., & Lin, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107268 · Cited by 23
“5610(28)) and cigarettes per day (P = 5610(216)) [44].”
BackgroundFehringer, G., Liu, G., Pintilie, M., Sykes, J. R., Cheng, D., Liu, N., Chen, Z., Seymour, L., Der, S. D., Shepherd, F. A., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1123-t · Cited by 23
Molecular changes in smoking-related lung cancer
Begum, S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.84 · Cited by 23
Ugolini, D., Neri, M., Aldo, C. P., Casilli, C., Catrambone, G., Paolo, I. G., Lando, C., Marroni, P., Paganuzzi, M., Parodi, B., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0524 · Cited by 26
Pleiotropic Analysis of Lung Cancer and Blood Triglycerides
Zuber, V., Marconett, C. N., Shi, J., Hua, X., Wheeler, W., Yang, C., Song, L., Dale, A. M., Laplana, M., Risch, A., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw167 · Cited by 23
“associated with lung cancer and smoking [12-13] (Supplementary Table 3,”
BackgroundSelf-citationWei, X., & Zhang, J. (2017) · Genetics · doi:10.1534/genetics.116.195487 · Cited by 24
“In humans, G3E has been implicated in cancer (Thorgeirsson et al. 2008), inflammatory disorder (Chamaillard et al. 2003), immune system diseases (Padyukov et al. 2004), and mental disorders (Risch et al. 2009; Byrd and Manuck 2014; Luck et al. 2014).”
BackgroundTaylor, M. R., Rode, L., Bjørngaard, J. H., Taylor, A. E., Bojesen, S. E., Åsvold, B. O., Gabrielsen, M. E., Lewis, G., Nordestgaard, B. G., Romundstad, P., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy027 · Cited by 23
“001 in UK Biobank), which is consistent with previous evidence that each additional copy of the risk allele is responsible for an approximately one-cigarette-per-day increase in smoking heaviness.(25,26) There was no evidence for association between rs1051730/rs16969968 and potential confounding factors in ALSPAC or U…”
α5‐nAChR modulates melanoma growth through the Notch1 signaling pathway
Dang, N., Meng, X., Qin, G., An, Y., Zhang, Q., Cheng, X., & Huang, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29435 · Cited by 22
“1 containing CHRNA5/A3/B4 is closely related to smoking and the development of lung cancer (Chu, Cho, & Shin, 2013; Grando, 2014; Grozio et al., 2007; Guo, Wu, & Zhou, 2011; Hung et al., 2008; Improgo, Scofield, Tapper, & Gardner, 2010; Sun, Jia, & Ma, 2017; Thorgeirsson et al., 2008).”
Lung Cancer Risk Models Come of Age
Field, J. K. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0144 · Cited by 22
Mobascher, A., Rujescu, D., Mittelstraß, K., Giegling, I., Lamina, C., Nitz, B., Brenner, H., Fehr, C., Breitling, L. P., Gallinat, J., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31011 · Cited by 23
Deflorio, C., Blanchard, S., Carisi, M. C., Bohl, D., & Maskos, U. (2016) · The FASEB Journal · doi:10.1096/fj.201600932r · Cited by 23
“Inparticular, thea5subunit containing thenonsynonymous variant rs16969968, a single-nucleotide polymorphism (SNP) inwhich the aspartic acid residue at position 398 is replaced with an asparagine (a5D398N), has been associated with increased use of tobacco (22, 23) and with a higher incidence of lung cancer (19, 24, 25…”
BackgroundNäslund‐Koch, C., Vedel‐Krogh, S., Bojesen, S. E., & Skov, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1119144 · Cited by 24
“The gene CHRNA3 is found in the nicotinic acetylcholine receptor gene cluster on chromosome 15 (14, 15).”
BackgroundDNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.
Doherty, J. A., Sakoda, L. C., Loomis, M. M., Barnett, M. J., Julianto, L., Thornquist, M. D., Neuhouser, M. L., Weiss, N. S., Goodman, G. E., & Chen, C. (2013) · Europe PMC (PubMed Central) · Cited by 21
Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers
Sakoda, L. C., Loomis, M. M., Doherty, J. A., Neuhouser, M. L., Barnett, M. J., Thornquist, M. D., Weiss, N. S., Goodman, G. E., & Chen, C. (2011) · Cancer Causes & Control · doi:10.1007/s10552-010-9716-1 · Cited by 21
Liu, W., Ao, L., Cui, Z., Zhou, Z., Zhou, Y.-H., Yuan, X., Xiang, Y., Cao, J., & Liu, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.067 · Cited by 21
Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population
Li, Z., Bao, S., Xu, X., Bao, Y., & Zhang, Y. (2012) · Translational Oncology · doi:10.1593/tlo.12304 · Cited by 21
“Sequence variants in CHRNA SNPs on chromosome 15 have been associated with increased (self-reported) cigarette dose and nicotine dependence [13] and increased risk of lung cancer in smokers [4,18], whereas association in nonsmokers was not [18].”
BackgroundMost Lung and Colon Cancer Susceptibility Genes Are Pair-Wise Linked in Mice, Humans and Rats
Quan, L., Stassen, A. P. M., Ruivenkamp, C. A. L., van Wezel, T., Fijneman, R. J. A., Hutson, A. D., Kakarlapudi, N., Hart, A. A. M., & Démant, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014727 · Cited by 24
“Orthologues of the colon cancer susceptibility loci at 18q21 [4] and 11q23 [9] and the lung cancer susceptibility loci at 5p15, 6p21 and 15q25 [12–14], are in regions that were not tested for Sluc or Scc loci.”
BackgroundWang, K.-S., Liu, X., Zhang, Q., & Min De, Z. E. N. G. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.02.003 · Cited by 23
A Sex-Specific Association between a 15q25 Variant and Upper Aerodigestive Tract Cancers
Chen, D., Truong, T., Gaborieau, V., Byrnes, G. B., Chabrier, A., Chuang, S., Olshan, A. F., Weissler, M. C., Luo, J., Romkes, M., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1008 · Cited by 22
“org Cancer Epidemiol Biomarkers Prev; 20(4) April 2011 659”
InfluentialWang, X., Ma, K., Chi, L., Cui, J., Jin, L., Hu, J., & Li, W. (2016) · Journal of Cancer · doi:10.7150/jca.13437 · Cited by 22
Johnsen, M. B., Winsvold, B. S., Børte, S., Vie, G. Å., Pedersen, L. M., Storheim, K., Skorpen, F., Hagen, K., Bjørngaard, J. H., Åsvold, B. O., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13675 · Cited by 24
“In smokers, each additional T allele of the rs1051730 SNP is associated with an increased intensity of smoking corresponding to around one additional cigarette per day [11,12].”
BackgroundResultChen, L.-S., Xian, H., Grucza, R. A., Saccone, N. L., Wang, J. C. C., Johnson, E. O., Breslau, N., Hatsukami, D. K., & Bierut, L. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.01.014 · Cited by 24
Les addictions sous l’angle de la génétique
Ramoz, N., & Gorwood, P. A. P. M. (2015) · médecine/sciences · doi:10.1051/medsci/20153104018 · Cited by 24
“Enzyme catabolisant la nicotine en cotinine [6-12]”
BackgroundBiology of Non–Small Cell Lung Cancer
Massion, P. P., & Carbone, D. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00045-6 · Cited by 21
Childhood socioeconomic status moderates genetic predisposition for peak smokingPreprint
Bierut, L. J., Biroli, P., Galama, T. J., & Thom, K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/336834 · Cited by 21
“Recent advances in molecular genetics, however, have established robust associations between specific genetic variants and smoking behavior (Liu et al., 2010; Thorgeirsson et al., 2008, 2010; The Tobacco and Genetics Consortium et al., 2010).”
BackgroundYoung, R. P., Hopkins, R. J., & Gamble, G. D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00210 · Cited by 22
The Five-Factor Model of Personality: Consensus and Controversy
McCrae, R. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.013 · Cited by 38
Zhu, A. Z. X., Renner, C. C., Hatsukami, D. K., Benowitz, N. L., & Tyndale, R. F. (2013) · Addiction · doi:10.1111/add.12250 · Cited by 21
“In this study we investigate whether gene variants in the α5, α3 and β4 nicotinic acetylcholine receptor gene cluster (CHRNA5A3-B4) are associated with nicotine intake and weight in Alaska Native people, as observed previously in smokers of European ancestry [5,6].”
Pu, X., Hildebrandt, M. A. T., Lu, C., Roth, J. A., Stewart, D. J., Zhao, Y. C., Heist, R. S., Ye, Y., Chang, D. W., Su, L., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.89 · Cited by 23
“Stage III 99 (58) 72 (42) 142 (88) 20 (12) 118 (84) 22 (16)”
Malhotra, J. D., Sartori, S., Brennan, P., Zaridze, D. G., Szeszenia‐Dąbrowska, N., Świątkowska, B., Rudnai, P., Lissowska, J., Fabiánová, E., Mateș, D., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1143-t · Cited by 21
“1 as a determinant of increased lung cancer risk (9-11).”
BackgroundBrenner, D. R., Amos, C. I., Brhane, Y., Timofeeva, M. N., Caporaso, N. E., Wang, Y., Christiani, D. C., Bickeböller, H., Yang, P., Albanes, D., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv128 · Cited by 21
Johnson, J. R., Rajamanoharan, D., McCue, H. V., Rankin, K., & Barclay, J. W. (2016) · Genetics · doi:10.1534/genetics.115.185025 · Cited by 21
“For nicotine dependence, GWAS studies have also identified metabolic enzymes (Thorgeirsson et al. 2008) as well as the endogenous pharmacological target for nicotine, the nicotinic acetylcholine receptors (Bierut et al. 2007; Liu et al. 2010; Kapoor et al. 2012).”
BackgroundPonemone, V., Gupta, S., Sethi, D., Suthar, M., Sharma, M. B., Powell, R. J., Harris, K. L., Jungla, N., Arambam, P., Kaul, U., et al. (2017) · Stem Cells International · doi:10.1155/2017/4137626 · Cited by 20
Functional variants in DCAF4 associated with lung cancer risk in European populations
Liu, H., Liu, Z., Wang, Y., Stinchcombe, T. E., Owzar, K., Han, Y., Hung, R. J., Brhane, Y., McLaughlin, J. R., Brennan, P., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx033 · Cited by 21
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How
Chen, L., Zawertailo, L. A., Piasecki, T. M., Kaprio, J. A., Foreman, M. G., Elliott, H. R., David, S. P., Bergen, A. W., Baurley, J. W., Tyndale, R. F., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx097 · Cited by 23
Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma
Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Song, F., Tang, J. Y., Sarin, K. Y., & Han, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30786 · Cited by 21
Antitumoral effects of fucoidan on bladder cancer
do-Amaral, C. C. F., Pacheco, B. S., Seixas, F. K., de Pereira, C. M. P., & Collares, T. V. (2020) · Algal Research · doi:10.1016/j.algal.2020.101884 · Cited by 21
The association between CHRN genetic variants and dizziness at first inhalation of cigarette smoke
Pedneault, M., Labbe, A., Roy‐Gagnon, M., Low, N. C. P., Dugas, E. N., Engert, J. C., & O’Loughlin, J. L. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.08.033 · Cited by 21
“, and lung cancer (Amos et al., 2010; Hung et al., 2008; Thorgeirsson et al., 2008).”
GPC5 rs2352028 variant and risk of lung cancer in never smokers
Landi, M. T., Chatterjee, N., Caporaso, N. E., Rotunno, M., Albanes, D., Thun, M. J., Wheeler, W., Rosenberger, A., Bickeböller, H., Risch, A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70096-6 · Cited by 20
Self-citationNicotinic Acetylcholine Receptor Variants Are Related to Smoking Habits, but Not Directly to COPD
Budulac, S. E., Vonk, J. M., Postma, D. S., Siedliński, M., Timens, W., & Boezen, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033386 · Cited by 23
“Furthermore, studies showed cross-sectional associations of the SNPs in the nAChR cluster with nicotine dependency based on the reported number of cigarettes per day [10] or the Fagerstrom Test of Nicotine Dependence (FTND), a test reliably predicting smoking cessation and correlating with biochemical measurements of…”
BackgroundResultInfluentialTeitelbaum, A. M., Murphy, S. E., Akk, G., Baker, T. B., Germann, A. L., von Weymarn, L. B., Bierut, L. J., Goate, A., Kharasch, E. D., & Bloom, A. J. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.92 · Cited by 21
Hadaruga, D. I., Hadaruga, N. G., Butnaru, G., Tatu, C. A., & Lukinich-Gruia, A. T. (2010) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-010-9761-0 · Cited by 19
Ke, J., Zhong, R., Zhang, T., Liu, L., Rui, R., Shen, N., Sun, Y., Liu, L., Cheng, L., & Miao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062485 · Cited by 19
Genetic Association Analysis of Complex Diseases Incorporating Intermediate Phenotype Information
Li, Y., Huang, J., & Amos, C. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046612 · Cited by 19
Associations of Nicotine Intake Measures With CHRN Genes in Finnish Smokers
Keskitalo‐Vuokko, K., Pitkäniemi, J. M., Broms, U., Heliövaara, M., Aromaa, A. J., Perola, M., Ripatti, S., Salminen, O., Salomaa, V. V., Loukola, A., et al. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr059 · Cited by 19
Associations between smoking behavior-related alleles and the risk of melanoma
Wu, W., Liu, H., Song, F., Chen, L.-S., Kraft, P. L., Wei, Q., & Han, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10144 · Cited by 20
“Those two loci have been found to be associated with lung cancer, chronic obstructive pulmonary disease and body mass index in never smokers [13, 20–23].”
BackgroundWang, J., Spiegel, N., Bertelsen, S. E., Le, N., McKenna, N. P., Budde, J., Harari, O., Kapoor, M., Brooks, A. I., Hancock, D. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080204 · Cited by 22
Xie, K., Ye, Y., Zeng, Y., Gu, J. H., Yang, H., & Wu, X. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx079 · Cited by 20
Fusco, J. P., Pita, G., Pajares, M. J., Andueza, M. P., Patiño‐García, A., de-Torres, J. P., Gúrpide, A., Zulueta, J. J., Alonso, R., Álvarez, N., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1500 · Cited by 22
Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism
Liu, J., Yao, Q., Xie, X., Cui, Q., Jiang, T., Zhao, Z., Du, X., Lai, B., Xiao, L., & Wang, N. (2022) · Nutrients · doi:10.3390/nu14091756 · Cited by 20
“It has been reported that nicotine plays a critical role in the development of many diseases, such as cardiovascular disorders and lung cancer [4].”
BackgroundOrloff, M. S., Zhang, L., Bebek, G., & Eng, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031975 · Cited by 21
Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung
Nguyen, J. D. U., Lamontagne, M., Couture, C., Conti, M., Paré, P. D., Sin, D. D., Hogg, J. C., Nickle, D. C., Postma, D. S., Timens, W., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu184 · Cited by 21
“The most strongly associated locus in populations of European descent is on chromosome 15q25, which is a region also associated with smoking behavior (11,12), nicotine addiction (3) and chronic obstructive pulmonary disease (13).”
BackgroundBoscarino, J. A., Kirchner, Hoffman, & Erlich (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s42422 · Cited by 19
“…gene cluster, which encodes components of the nicotinic acetylcholine receptor, is associated with nicotine dependence and cigarette smoking, 62,63 substance misuse, 54 and, more recently, PTSD. 12,25 The CRHR1 gene is associated with a polypeptide hormone and neurotransmitters involved in…”
Metadata
- Authors
- Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsäter, A., Flex, A., Aben, K. K. H., de Vegt, F., Mulders, P. F. A., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- University of Otago (NZ)
- Convent Hospital of the Brothers of Saint John of God (AT)
- Skåne University Hospital (SE)
- Università Cattolica del Sacro Cuore (IT)
- Radboud University Medical Center (NL)
- Hospital Universitario Reina Sofía (ES)
- National University Hospital of Iceland (IS)
- Instituto de Nanociencia y Materiales de Aragón (ES)
- Corresponding author
- Thorgeirsson, Thorgeir E.
- ORCID
- Venue
- Nature
- Published
- 2008-04
- Volume
- 452
- Issue
- 7187
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4539558
- OpenAlex
- W2118082971
- Cited by
- 1,523
- References
- 45
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 29 · 2023: 41 · 2022: 33 · 2021: 36 · 2020: 94 · 2019: 48 · 2018: 56 · 2017: 79 · 2016: 80 · 2015: 107 · 2014: 91 · 2013: 100 · 2012: 145
- FWCI
- 120.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- European Commission
- National Institute on Drug Abuse (R01DA017932)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotinic acetylcholine receptors, nicotine dependence, smoking quantity, lung cancer susceptibility, peripheral arterial disease, gene-environment interaction, genetic susceptibility, smoking-related diseases
- MeSH terms
- Chromosomes, Human, Pair 15, Europe, Female, Multigene Family, Genotype, Humans, Lung Neoplasms, Male, New Zealand, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Odds Ratio, Peripheral Vascular Diseases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.